The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial).

Por Hubert Kolb, Kathrin Lückemeyer, Tim Heise, Christian Herder, Nanette C Schloot, Wolfgang Koenig, Lutz Heinemann, Stephan Martin, DIATOR Study Group
Publicado em 2013-01-01

Type 2 Diabetes Phenotype and Progression Is Significantly Different if Diagnosed before versus after 65 Years of Age

Por Hubert Kolb, Berthold Schneider, Lutz Heinemann, Tim Heise, Volker Lodwig, Jacques K. Tshiang Tshiananga, Christian Weber, Werner A. Scherbaum, Stephan Martin
Publicado em 2008